Stapleton AE (2016) The vaginal microbiota and urinary tract infection. Microbiol Spectr 4(6):4 6.37. https://doi.org/10.1128/microbiolspec.uti-0025-2016
Tan-Kim J, Shah NM, Do D et al (2023) Efficacy of vaginal Estrogen for recurrent urinary tract infection prevention in hypoestrogenic women. Am J Obstet Gynecol 229(2):143.e1–143.e9. https://doi.org/10.1016/j.ajog.2023.05.002
Article PubMed CAS Google Scholar
Sjögren LL, Mørch LS, Løkkegaard E (2016) Hormone replacement therapy and the risk of endometrial cancer: a systematic review. Maturitas 91:25–35. https://doi.org/10.1016/j.maturitas.2016.05.013
Article PubMed CAS Google Scholar
Gambacciani M, Fidecicchi T (2022) Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study. Climacteric 25(2):208–211. https://doi.org/10.1080/13697137.2021.2014809
Article PubMed CAS Google Scholar
Woźniak A, Woźniak S, Poleszak E et al (2023) Efficacy of fractional CO2 laser treatment for genitourinary syndrome of menopause in short-term evaluation-preliminary study. Biomedicines 11(5):1304. https://doi.org/10.3390/biomedicines11051304
Article PubMed PubMed Central CAS Google Scholar
Sarmento AC, Fernandes FS, Marconi C et al (2020) Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women. Clinics 75:e1750. https://doi.org/10.6061/clinics/2020/e1750
Article PubMed PubMed Central Google Scholar
Karcher C, Sadick N (2016) Vaginal rejuvenation using energy-based devices. Int J Womens Dermatol 2(3):85–88. https://doi.org/10.1016/j.ijwd.2016.05.003
Article PubMed PubMed Central Google Scholar
FDA Warns Against Use of Energy-Based (2018) Devices to perform vaginal ‘‘rejuvenation’’ or vaginal cosmetic procedures: FDA safety communication. Date Issued: July 30, https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-efforts-safeguard-womens-health-deceptive-health-claims
Guo JZ, Souders C, McClelland L et al (2020) Vaginal laser treatment of genitourinary syndrome of menopause: does the evidence support the FDA safety communication? Menopause 27(10):1177–1184. https://doi.org/10.1097/GME.0000000000001577
Lukac M, Gaspar A, Bajd F (2018) Dual tissue regeneration: Non-ablative resurfacing of soft tissues with FotonaSmooth® mode er:yag laser. J Laser Health Acad 2018(1):1–15
Gambacciani M, Levancini M, Russo E et al (2018) Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric 21(2):148–152. https://doi.org/10.1080/13697137.2018.1436538
Article PubMed CAS Google Scholar
Gaspar A, Maestri S, Silva J et al (2018) Intraurethral erbium:yag laser for the management of urinary symptoms of genitourinary syndrome of menopause: a pilot study. Lasers Surg Med 50(8):802–807. https://doi.org/10.1002/lsm.22826
Article PubMed PubMed Central Google Scholar
Mitsuyuki M, Štok U, Hreljac I et al (2020) Treating vaginal laxity using nonablative Er:yag laser: a retrospective case series of patients from 2.5 years of clinical practice. Sex Med 8(2):265–273. https://doi.org/10.1016/j.esxm.2020.01.001
Article PubMed PubMed Central Google Scholar
Syed AH, Feras A, Pilippe EZ (2015) Long-term efficacy of fulguration of trigonitis for recurrent urinary tract infections in women. Urol Sci 26(3):197–201. https://doi.org/10.1016/j.urols.2015.08.005
Yang K, Xu M, Zhong F et al (2018) Rapid differentiation of Lactobacillus species via metabolic profiling. J Microbiol Methods 154:147–155. https://doi.org/10.1016/j.mimet.2018.10.013
Article PubMed CAS Google Scholar
Bachmann GA, Notelovitz M, Kelly SJ et al (1992) Long-term non-hormonal treatment of vaginal dryness. Clin Pract Sexuality 8:3–8
Raz R, Stamm WE (1993) A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 11:753–756. https://doi.org/10.1056/NEJM199309093291102
Bixler BR, Anger JT (2022) Updates to recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol 208(4):754–756. https://doi.org/10.1097/JU.0000000000002888
Ikahelmo R, Siitonen A, Heiskanen T et al (1996) Recurrence of urinary tract infection in a primary care setting: analysis of a I-year follow-up of 179 women. Clin Infect Dis 22(1):91–99. https://doi.org/10.1093/clinids/22.1.91
Harris E (2023) Updated meta-analysis: cranberry products reduced UTI risk. JAMA 329(20):1730. https://doi.org/10.1001/jama.2023.7761
Snellings MS, Linnebur SA, Pearson SM et al (2020) Effectiveness of methenamine for UTI prevention in older adults. Ann Pharmacother 54(4):359–363. https://doi.org/10.1177/1060028019886308
Kyriakides R, Jones P, Somani BK (2021) Role of d-mannose in the prevention of recurrent urinary tract infections: evidence from a systematic review of the literature. Eur Urol Focus 7(5):1166–1169. https://doi.org/10.1016/j.euf.2020.09.004
Zerbinati N, Serati M, Origoni M et al (2015) Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci 30(1):429–436. https://doi.org/10.1007/s10103-014-1677-2
Zipper R, Lamvu G (2022) Vaginal laser therapy for gynecologic conditions: re-examining the controversy and where do we go from here. J Comp Eff Res 11(11):843–851. https://doi.org/10.2217/cer-2021-0281
Article PubMed CAS Google Scholar
Athanasiou S, Pitsouni E, Antonopoulou S et al (2016) The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women. Climacteric 19(5):512–518. https://doi.org/10.1080/13697137.2016.1212006
Article PubMed CAS Google Scholar
Nuttanun P, Krasean P, Ammarin S (2023) Number of vaginal lactobacilli in postmenopausal women with vaginal atrophy before and after treatment with erbium-YAG laser: a randomized sham-controlled trial. BMC Womens Health 23(1):513. https://doi.org/10.1186/s12905-023-02590-y
Mitchell ES, Woods NF (2013) Correlates of urinary incontinence during the menopausal transition and early postmenopause: observations from the Seattle midlife women’s health study. Climacteric 16(6):653–662. https://doi.org/10.3109/13697137.2013.777038
Article PubMed CAS Google Scholar
Li J, Li H, Zhou Y et al (2013) The fractional CO2 laser for the treatment of genitourinary syndrome of menopause: A prospective multicenter cohort study. Lasers Surg Med 53(5):647–653. https://doi.org/10.1002/lsm.23346
Qi Y, Mo K, Wang A et al (2024) Different effects of CO2 laser and estrogen treatment on vaginal mucosa microbiota and function in genitourinary syndrome of menopause patients. J Obstet Gynaecol Res 50(4):671–681. https://doi.org/10.1111/jog.15876
Article PubMed CAS Google Scholar
Alshiek J, Garcia B, Minassian V et al (2020) Vaginal energy-based devices. Female Pelvic Med Reconstr Surg 26(5):287–298. https://doi.org/10.1097/SPV.0000000000000872
Tadir Y, Gaspar A, Lev-Sagie A et al (2017) Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies. Lasers Surg Med 49(2):137–159. https://doi.org/10.1002/lsm.22637
Article PubMed PubMed Central Google Scholar
Undeberg M, Barash A, McKeirnan K (2023) Role of the pharmacist in the management of postmenopausal breast cancer treatment with vasomotor symptoms: a case report. Explor Res Clin Soc Pharm 11:100324. https://doi.org/10.1016/j.rcsop.2023.100324
Article PubMed PubMed Central Google Scholar
Beste M, Kaunitz A, McKinney J et al (2025) Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality risks. Am J Obstet Gynecol 232(3):262–270e1.
Comments (0)